Pharsight

Drugs that contain Perampanel

1. Fycompa patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6949571 EISAI INC 1,2-dihydropyridine compounds, process for preparation of the same and use thereof
Jun, 2024

(2 months from now)

US8772497 EISAI INC Method for producing 1, 2-dihydropyridine-2-one compound
Jul, 2026

(2 years from now)

Market Authorisation Date: 29 April, 2016

Treatment: Treatment of primary generalized tonic-clonic seizures as adjunctive therapy in patients with epilepsy 12 years of age and older; Treatment of partial-onset seizures with or without secondarily genera...

Dosage: SUSPENSION;ORAL

How can I launch a generic of FYCOMPA before it's drug patent expiration?
More Information on Dosage

FYCOMPA family patents

Family Patents